ArticlePloS one2026
In silico antimicrobial resistance profiling of 1,240 Stenotrophomonas maltophilia genomes: AMR gene prevalence, temporal evolution, and ST-specific associations.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stenotrophomonas maltophilia is an opportunistic pathogen with clinically important multidrug resistance, yet large-scale genome-based analyses integrating population structure, resistance determinants, and epidemiological metadata remain limited. We analyzed 2,419 publicly available genomes retrieved from NCBI GenBank. After quality control with CheckM, 2,389 assemblies passed filtering criteria, and species identity was further evaluated by average nucleotide identity using FastANI. A final curated dataset of 1,240 confirmed S. maltophilia genomes was retained for downstream analyses. Antimicrobial resistance determinants were identified using AMRFinderPlus, sequence types were assigned by multilocus sequence typing, and temporal, geographic, host-associated, and gene co-occurrence analyses were performed. The 1,240 genomes represented isolates collected between 1900 and 2025 from 40 countries. Geographic metadata were available for 1,239 isolates, host source for 1,239 isolates, and collection year for 1,105 isolates. Human-derived isolates predominated, whereas animal-derived isolates were rare and environmental isolates were absent. MLST assigned 876 isolates to 97 sequence types, with ST5, ST4, ST1, ST31, and ST162 as the most prevalent lineages. The resistome comprised 69 unique resistance-associated genes across 12 functional classes and showed a bimodal structure, with a highly conserved intrinsic core and a sparse accessory component. Core genes included emrA, emrB, emrC, smeF, blaL1, aac(6')-Iz, aph(6), aph(3')-IIc, ermB, and ermC, most of which occurred at very high prevalence. In contrast, acquired determinants such as sul2, tet(G), aadA2, blaNDM-1, blaGES-1, and blaOXA-74 were infrequent. Plasmid replicons were also uncommon, supporting a predominantly chromosomal resistance architecture. Temporal analyses showed that intrinsic genes were present in the earliest available isolates, whereas acquired genes appeared only in recent decades and generally remained rare. Several acquired genes, including floR, aph(3'')-Ib, aph(6)-Id, and aac(6')-Ib4, declined over time, while no acquired resistance determinant showed a significant increasing trend. Gene presence pattern and co-occurrence analyses identified dominant conserved resistome configurations and a smaller set of variable accessory modules associated with putative mobile genetic elements. Comparative analysis further showed enrichment of intrinsic efflux-associated determinants in clinical isolates, whereas non-clinical isolates carried a broader diversity of acquired aminoglycoside resistance genes. These findings indicate that the global resistome of S. maltophilia is dominated by conserved intrinsic, chromosomally encoded resistance determinants, whereas acquired resistance genes remain rare, sporadic, and lineage-associated. This curated genome-scale framework provides a resource for surveillance and for future studies linking resistome evolution, mobile genetic elements, and genotype-phenotype relationships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.